Here are three things to know about Dr. Califf.
1. He joined the FDA as deputy commissioner earlier this year from Durham, N.C.-based Duke University, where he had served as a professor of medicine, a leading pharmaceutical researcher and the vice chancellor for clinical and translational research.
2. He has led many pivotal clinical trials, been among the most cited medical authors in the U.S. and for years served on various FDA advisory committees, according to the report.
3. If confirmed by the U.S. Senate, Dr. Califf will replace Stephen Ostroff, MD, who has served as acting commissioner since Margaret Hamburg, MD, stepped down earlier this year.
More articles on leadership and management:
KishHealth System CEO honored with AHA Grassroots Champions Award
Donald Trump calls CEO pay ‘a complete joke’
When’s the best time of day to take a break?
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
